Selenium and its supplementation in cardiovascular disease—what do we know?

Nutrients

Volumn 7, Issue 5, 2015, Pages 3094-3118

  Benstoem, Carina ^a   Goetzenich, Andreas ^a   Kraemer, Sandra ^a   Borosch, Sebastian ^a   Manzanares, William ^b   Hardy, Gil ^c   Stoppe, Christian ^a,d  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^c MASSEY UNIVERSITY   (New Zealand)

^d RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Cardiac surgery; Cardiovascular disease; Coronary heart disease; Selenium selenoproteins

Indexed keywords

GLUTATHIONE PEROXIDASE; METHIONINE SULFOXIDE REDUCTASE B; SELENIUM; SELENOPROTEIN; THIOREDOXIN REDUCTASE; THYROID HORMONE; THYROXINE DEIODINASE; ANTIOXIDANT; TRACE ELEMENT;

ANTIOXIDANT ACTIVITY; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; DIET SUPPLEMENTATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART SURGERY; IMMUNOCOMPETENT CELL; INFLAMMATION; ISCHEMIC HEART DISEASE; KESHAN DISEASE; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION INJURY; REVIEW; DIET THERAPY; DIETARY SUPPLEMENT; HUMAN; METABOLISM;

ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DIETARY SUPPLEMENTS; HUMANS; SELENIUM; SELENOPROTEINS; TRACE ELEMENTS;

EID: 84929358912     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7053094     Document Type: Review

References (125)

1. Muth, O. H.; Oldfield, J. E.; Remmert, L. F.; Schubert, J. R. Effects of selenium and vitamin E on white muscle disease. Science 1958, 128, 1090.
2. Navarro-Alarcon, M.; Cabrera-Vique, C. Selenium in food and the human body: A review. Sci. Total Environ. 2008, 400, 115-141.
3. Thomson, C. D. Assessment of requirements for selenium and adequacy of selenium status: Areview. Eur. J. Clin. Nutr. 2004, 58, 391-402.
4. Fairweather-Tait, S. J.; Bao, Y.; Broadley, M. R.; Collings, R.; Ford, D.; Hesketh, J. E.; Hurst, R. Selenium in human health and disease. Antioxid. Redox Signal. 2011, 14, 1337-1383.
5. Yang, G.; Ge, K.; Chen, J.; Chen, X. Selenium-related endemic diseases and the daily selenium requirement of humans. World Rev. Nutr. Diet. 1988, 55, 98-152.
6. MacFarquhar, J. K.; Broussard, D. L.; Melstrom, P.; Hutchinson, R.; Wolkin, A.; Martin, C.; Burk, R. F.; Dunn, J. R.; Green, A. L.; Hammond, R.; et al. Acute selenium toxicity associated with a dietary supplement. Arch. Intern. Med. 2010, 170, 256-261.
7. Rayman, M. P. Food-chain selenium and human health: Emphasis on intake. Br. J. Nutr. 2008, 100, 254-268.
8. Lech, T. Suicide by sodium tetraoxoselenate(VI) poisoning. Forensic Sci. Int. 2002, 130, 44-48.
9. Arthur, J. R.; McKenzie, R. C.; Beckett, G. J. Selenium in the immune system. J. Nutr. 2003, 133, 1457S-1459S.
10. McKenzie, R. C.; Rafferty, T. S.; Beckett, G. J. Selenium: An essential element for immune function. Immunol. Today 1998, 19, 342-345.
11. Kiremidjian-Schumacher, L.; Roy, M. Selenium and immune function. Z. Ernahrungswiss. 1997, 37, 50-56.
12. Ahrens, I.; Ellwanger, C.; Smith, B. K.; Bassler, N.; Chen, Y. C.; Neudorfer, I.; Ludwig, A.; Bode, C.; Peter, K. Selenium supplementation induces metalloproteinase-dependent L-selectin shedding from monocytes. J. Leukoc. Biol. 2008, 83, 1388-1395.
13. Heyland, D. K.; Dhaliwal, R.; Suchner, U.; Berger, M. M. Antioxidant nutrients: A systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med. 2004, 31, 327-337.
14. Forman, H. J.; Torres, M. Reactive oxygen species and cell signaling: Respiratory burst in macrophage signaling. Am. J. Respir. Crit. Care Med. 2002, 166, S4-S8.
15. Arbogast, S.; Ferreiro, A. Selenoproteins and protection against oxidative stress: Selenoprotein N as a novel player at the crossroads of redox signaling and calcium homeostasis. Antioxid. Redox Signal. 2010, 12, 893-904.
16. Flores-Mateo, G.; Navas-Acien, A.; Pastor-Barriuso, R.; Guallar, E. Selenium and coronary heart disease: A meta-analysis. Am. J. Clin. Nutr. 2006, 84, 762-773.
17. Rees, K.; Hartley, L.; Day, C.; Flowers, N.; Clarke, A.; Stranges, S. Selenium supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 2013, 1, doi: 10. 1002/14651858. CD009671. pub2.
18. Loscalzo, J. Keshan disease, selenium deficiency, and the selenoproteome. N. Engl. J. Med. 2014, 370, 1756-1760.
19. Schrauzer, G. N. Selenomethionine: A review of its nutritional significance, metabolism and toxicity. J. Nutr. 2000, 130, 1653-1656.
20. Hardy, G.; Hardy, I.; Manzanares, W. Selenium supplementation in the critically ill. Nutr. Clin. Pract. 2012, 27, 21-33.
21. Reeves, M. A.; Hoffmann, P. R. The human selenoproteome: Recent insights into functions and regulation. Cell. Mol. Life Sci. 2009, 66, 2457-2478.
22. Grumolato, L.; Ghzili, H.; Montero-Hadjadje, M.; Gasman, S.; Lesage, J.; Tanguy, Y.; Galas, L.; Ait-Ali, D.; Leprince, J.; Guerineau, N. C.; et al. Selenoprotein T is a PACAP-regulated gene involved in intracellular Ca2+ mobilization and neuroendocrine secretion. FASEB J. 2008, 22, 1756-1768.
23. Prevost, G.; Arabo, A.; Jian, L.; Quelennec, E.; Cartier, D.; Hassan, S.; Falluel-Morel, A.; Tanguy, Y.; Gargani, S.; Lihrmann, I.; et al. The PACAP-regulated gene selenoprotein T is abundantly expressed in mouse and human beta-cells and its targeted inactivation impairs glucose tolerance. Endocrinology 2013, 154, 3796-3806.
24. Papp, L. V.; Lu, J.; Holmgren, A.; Khanna, K. K. From selenium to selenoproteins: Synthesis, identity, and their role in human health. Antioxid. Redox Signal. 2007, 9, 775-806.
25. Huang, Z.; Rose, A. H.; Hoffmann, P. R. The role of selenium in inflammation and immunity: From molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 2012, 16, 705-743.
26. Brigelius-Flohé, R.; Maiorino, M. Glutathione peroxidases. Biochim. Biophys. Acta 2013, 1830, 3289-3303.
27. Flohe, L.; Gunzler, W. A.; Schock, H. H. Glutathione peroxidase: A selenoenzyme. FEBS Lett. 1973, 32, 132-134.
28. Rotruck, J. T. Selenium: Biochemical role as a component of glutathione peroxidase. Science 1973, 179, 588-590.
29. Yoshida, T.; Watanabe, M.; Engelman, D. T.; Engelman, R. M.; Schley, J. A.; Maulik, N.; Ho, Y. S.; Oberley, T. D.; Das, D. K. Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion injury. J. Mol. Cell. Cardiol. 1996, 28, 1759-1767.
30. Yoshida, T.; Maulik, N.; Engelman, R. M.; Ho, Y. S.; Magnenat, J. L.; Rousou, J. A.; Flack, J. E.; Deaton, D.; Das, D. K. Glutathione peroxidase knockout mice are susceptible to myocardial ischemia reperfusion injury. Circulation 1997, 96, 216-220.
31. Lim, C. C.; Bryan, N. S.; Jain, M.; Garcia-Saura, M. F.; Fernandez, B. O.; Sawyer, D. B.; Handy, D. E.; Loscalzo, J.; Feelisch, M.; Liao, R. Glutathione peroxidase deficiency exacerbates ischemia-reperfusion injury in male but not female myocardium: Insights into antioxidant compensatory mechanisms. Am. J. Physiol. Heart Circ. Physiol. 2009, 297, H2144-H2153.
32. Jin, R. C.; Mahoney, C. E.; Anderson, L. C.; Ottaviano, F.; Croce, K.; Leopold, J. A.; Zhang, Y. Y.; Tang, S. S.; Handy, D. E.; Loscalzo, J. Glutathione peroxidase-3 deficiency promotes platelet-dependent thrombosis in vivo. Circulation 2011, 123, 1963-1973.
33. Brigelius-Flohé, R.; Banning, A.; Schnurr, K. Selenium-dependent enzymes in endothelial cell function. Antioxid. Redox Signal. 2003, 5, 205-215.
34. Hoffmann, F. W.; Hashimoto, A. S.; Lee, B. C.; Rose, A. H.; Shohet, R. V.; Hoffmann, P. R. Specific antioxidant selenoproteins are induced in the heart during hypertrophy. Arch. Biochem. Biophys. 2011, 512, 38-44.
35. Wortmann, M.; Schneider, M.; Pircher, J.; Hellfritsch, J.; Aichler, M.; Vegi, N.; Kölle, P.; Kuhlencordt, P.; Walch, A.; Pohl, U.; et al. Combined deficiency in glutathione peroxidase 4 and vitamin E causes multiorgan thrombus formation and early death in mice. Circ. Res. 2013, 113, 408-417.
36. Hollander, J. M.; Lin, K. M.; Scott, B. T.; Dillmann, W. H. Overexpression of PHGPx and HSP60/10 protects against ischemia/reoxygenation injury. Free Radic. Biol. Med. 2003, 35, 742-751.
37. Rose, A. H.; Hoffmann, P. R. Selenoproteins and cardiovascular stress. Thromb. Haemost. 2015, 113, 494-504.
38. Arner, E. S.; Holmgren, A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. FEBS 2000, 267, 6102-6109.
39. Maulik, N.; Das, D. K. Emerging potential of thioredoxin and thioredoxin interacting proteins in various disease conditions. Biochim. Biophys. Acta 2008, 1780, 1368-1382.
40. Biterova, E. I.; Turanov, A. A.; Gladyshev, V. N.; Barycki, J. J. Crystal structures of oxidized and reduced mitochondrial thioredoxin reductase provide molecular details of the reaction mechanism. Proc. Natl. Acad. Sci. USA 2005, 102, 15018-15023.
41. Holmgren, A.; Lu, J. Thioredoxin and thioredoxin reductase: Current research with special reference to human disease. Biochem. Biophys. Res. Commun. 2010, 396, 120-124.
42. Tamura, T.; Stadtman, T. C. A new selenoprotein from human lung adenocarcinoma cells: Purification, properties, and thioredoxin reductase activity. Proc. Natl. Acad. Sci. USA 1996, 93, 1006-1011.
43. Lee, S. R.; Kim, J. R.; Kwon, K. S.; Yoon, H. W.; Levine, R. L.; Ginsburg, A.; Rhee, S. G. Molecular cloning and characterization of a mitochondrial selenocysteine-containing thioredoxin reductase from rat liver. J. Biol. Chem. 1999, 274, 4722-4734.
44. Sun, Q. A.; Kirnarsky, L.; Sherman, S.; Gladyshev, V. N. Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems. Proc. Natl. Acad. Sci. USA 2001, 98, 3673-3678.
45. Lundstrom, J.; Holmgren, A. Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity. J. Biol. Chem. 1990, 265, 9114-9120.
46. Lundstrom-Ljung, J.; Birnbach, U.; Rupp, K.; Soling, H. D.; Holmgren, A. Two resident ER-proteins, CaBP1 and CaBP2, with thioredoxin domains, are substrates for thioredoxin reductase: Comparison with protein disulfide isomerase. FEBS Lett. 1995, 357, 305-308.
47. Bjornstedt, M.; Hamberg, M.; Kumar, S.; Xue, J.; Holmgren, A. Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH and selenocystine strongly stimulates the reaction via catalytically generated selenols. J. Biol. Chem. 1995, 270, 11761-11764.
48. Bjornstedt, M.; Kumar, S.; Holmgren, A. Selenodiglutathione is a highly efficient oxidant of reduced thioredoxin and a substrate for mammalian thioredoxin reductase. J. Biol. Chem. 1992, 267, 8030-8034.
49. Gromer, S.; Gross, J. H. Methylseleninate is a substrate rather than an inhibitor of mammalian thioredoxin reductase. Implications for the antitumor effects of selenium. J. Biol. Chem. 2002, 277, 9701-9706.
50. Kumar, S.; Bjornstedt, M.; Holmgren, A. Selenite is a substrate for calf thymus thioredoxin reductase and thioredoxin and elicits a large non-stoichiometric oxidation of NADPH in the presence of oxygen. Eur. J. Biochem. FEBS 1992, 207, 435-439.
51. Ganther, H. E. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: Complexities with thioredoxin reductase. Carcinogenesis 1999, 20, 1657-1666.
52. Tanaka, K.; Honda, M.; Takabatake, T. Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte. J. Am. Coll. Cardiol. 2001, 37, 676-685.
53. Berndt, C.; Lillig, C. H.; Holmgren, A. Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: Implications for diseases in the cardiovascular system. Am. J. Physiol. Heart Circ. Physiol. 2007, 292, H1227-H1236.
54. Yamamoto, M.; Yang, G.; Hong, C.; Liu, J.; Holle, E.; Yu, X.; Wagner, T.; Vatner, S. F.; Sadoshima, J. Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J. Clin. Investig. 2003, 112, 1395-1406.
55. Ago, T.; Sadoshima, J. Thioredoxin and ventricular remodeling. J. Mol. Cell. Cardiol. 2006, 41, 762-773.
56. Wang, L.; Proud, C. G. Ras/Erk signaling is essential for activation of protein synthesis by Gq protein-coupled receptor agonists in adult cardiomyocytes. Circ. Res. 2002, 91, 821-829.
57. Schomburg, L.; Köhrle, J. On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health. Mol. Nutr. Food Res. 2008, 52, 1235-1246.
58. Mittag, J.; Behrends, T.; Hoefig, C. S.; Vennström, B.; Schomburg, L. Thyroid hormones regulate selenoprotein expression and selenium status in mice. PLoS ONE 2010, 5, e12931.
59. Bianco, A. C.; Salvatore, D.; Gereben, B.; Berry, M. J.; Larsen, P. R. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr. Rev. 2002, 23, 38-89.
60. Klein, I.; Ojamaa, K. Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 2001, 344, 501-509.
61. Trivieri, M. G.; Oudit, G. Y.; Sah, R.; Kerfant, B. G.; Sun, H.; Gramolini, A. O.; Pan, Y.; Wickenden, A. D.; Croteau, W.; de Escobar, G. M.; et al. Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction. Proc. Natl. Acad. Sci. USA 2006, 103, 6043-6048.
62. Stadtman, E. R. Protein oxidation and aging. Free Radic. Res. 2006, 40, 1250-1258.
63. Moskovitz, J.; Bar-Noy, S.; Williams, W. M.; Requena, J.; Berlett, B. S.; Stadtman, E. R. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc. Natl. Acad. Sci. USA 2001, 98, 12920-12925.
64. Moskovitz, J.; Flescher, E.; Berlett, B. S.; Azare, J.; Poston, J. M.; Stadtman, E. R. Overexpression of peptide-methionine sulfoxide reductase in Saccharomyces cerevisiae and human T cells provides them with high resistance to oxidative stress. Proc. Natl. Acad. Sci. USA 1998, 95, 14071-14075.
65. Kim, H. Y.; Gladyshev, V. N. Methionine sulfoxide reduction in mammals: Characterization of methionine-R-sulfoxide reductases. Mol. Biol. Cell 2004, 15, 1055-1064.
66. Picot, C. R.; Perichon, M.; Lundberg, K. C.; Friguet, B.; Szweda, L. I.; Petropoulos, I. Alterations in mitochondrial and cytosolic methionine sulfoxide reductase activity during cardiac ischemia and reperfusion. Exp. Gerontol. 2006, 41, 663-667.
67. Lee, B. C.; Peterfi, Z.; Hoffmann, F. W.; Moore, R. E.; Kaya, A.; Avanesov, A.; Tarrago, L.; Zhou, Y.; Weerapana, E.; Fomenko, D. E.; et al. MsrB1 and MICALs regulate actin assembly and macrophage function via reversible stereoselective methionine oxidation. Mol. Cell 2013, 51, 397-404.
68. Lu, C.; Qiu, F.; Zhou, H.; Peng, Y.; Hao, W.; Xu, J.; Yuan, J.; Wang, S.; Qiang, B.; Xu, C.; et al. Identification and characterization of selenoprotein K: An antioxidant in cardiomyocytes. FEBS Lett. 2006, 580, 5189-5197.
69. Meiler, S.; Baumer, Y.; Huang, Z.; Hoffmann, F. W.; Fredericks, G. J.; Rose, A. H.; Norton, R. L.; Hoffmann, P. R.; Boisvert, W. A. Selenoprotein K is required for palmitoylation of CD36 in macrophages: Implications in foam cell formation and atherogenesis. J. Leukoc. Biol. 2013, 93, 771-780.
70. Cox, A. J.; Lehtinen, A. B.; Xu, J.; Langefeld, C. D.; Freedman, B. I.; Carr, J. J.; Bowden, D. W. Polymorphisms in the Selenoprotein S gene and subclinical cardiovascular disease in the Diabetes Heart Study. Acta Diabetol. 2013, 50, 391-399.
71. Gao, Y.; Feng, H. C.; Walder, K.; Bolton, K.; Sunderland, T.; Bishara, N.; Quick, M.; Kantham, L.; Collier, G. R. Regulation of the selenoprotein SelS by glucose deprivation and endoplasmic reticulum stress-SelS is a novel glucose-regulated protein. FEBS Lett. 2004, 563, 185-190.
72. Xu, G. L.; Wang, S. C.; Gu, B. Q.; Yang, Y. X.; Song, H. B.; Xue, W. L.; Liang, W. S.; Zhang, P. Y. Further investigation on the role of selenium deficiency in the aetiology and pathogenesis of Keshan disease. Biomed. Environ. Sci. 1997, 10, 316-326.
73. Beck, M. A.; Levander, O. A.; Handy, J. Selenium deficiency and viral infection. J. Nutr. 2003, 133, 1463S-1467S.
74. Beck, M. A.; Handy, J.; Levander, O. A. Host nutritional status: The neglected virulence factor. Trends Microbiol. 2004, 12, 417-423.
75. Jun, E. J.; Ye, J. S.; Hwang, I. S.; Kim, Y. K.; Lee, H. Selenium deficiency contributes to the chronic myocarditis in coxsackievirus-infected mice. Acta Virol. 2011, 55, 23-29.
76. Beck, M. A.; Esworthy, R. S.; Ho, Y. S.; Chu, F. F. Glutathione peroxidase protects mice from viral-induced myocarditis. FASEB J. 1998, 12, 1143-1149.
77. Venardos, K. Effects of dietary selenium on glutathione peroxidase and thioredoxin reductase activity and recovery from cardiac ischemia-reperfusion. J. Trace Elem. Med. Biol. 2004, 18, 81-88.
78. Toufektsian, M. C.; Boucher, F.; Pucheu, S.; Tanguy, S.; Ribuot, C.; Sanou, D.; Tresallet, N.; de Leiris, J. Effects of selenium deficiency on the response of cardiac tissue to ischemia and reperfusion. Toxicology 2000, 148, 125-132.
79. Tanguy, S.; Toufektsian, M. C.; Besse, S.; Ducros, V.; de Leiris, J.; Boucher, F. Dietary selenium intake affects cardiac susceptibility to ischaemia/reperfusion in male senescent rats. Age Ageing 2003, 32, 273-278.
80. Pucheu, S.; Coudray, C.; Tresallet, N.; Favier, A.; de Leiris, J. Effect of dietary antioxidant trace element supply on cardiac tolerance to ischemia-reperfusion in the rat. J. Mol. Cell. Cardiol. 1995, 27, 2303-2314.
81. Venardos, K. M.; Perkins, A.; Headrick, J.; Kaye, D. M. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: A review. Curr. Med. Chem. 2007, 14, 1539-1549.
82. Tanguy, S.; Boucher, F.; Besse, S.; Ducros, V.; Favier, A.; de Leiris, J. Trace elements and cardioprotection: Increasing endogenous glutathione peroxidase activity by oral selenium supplementation in rats limits reperfusion-induced arrhythmias. J. Trace Elem. Med. Biol. 1998, 12, 28-38.
83. Tanguy, S.; Morel, S.; Berthonneche, C.; Toufektsian, M. C.; de Lorgeril, M.; Ducros, V.; Tosaki, A.; de Leiris, J.; Boucher, F. Preischemic selenium status as a major determinant of myocardial infarct size in vivo in rats. Antioxid. Redox Signal. 2004, 6, 792-796.
84. Tanguy, S.; Rakotovao, A.; Jouan, M. G.; Ghezzi, C.; de Leiris, J.; Boucher, F. Dietary selenium intake influences Cx43 dephosphorylation, TNF-α expression and cardiac remodeling after reperfused infarction. Mol. Nutr. Food Res. 2011, 55, 522-529.
85. Rakotovao, A.; Tanguy, S.; Toufektsian, M. C.; Berthonneche, C.; Ducros, V.; Tosaki, A.; de Leiris, J.; Boucher, F. Selenium status as determinant of connexin-43 dephosphorylation in ex vivo ischemic/reperfused rat myocardium. J. Trace Elem. Med. Biol. 2005, 19, 43-47.
86. Rotruck, J. T. Prevention of oxidative damage to rat erythrocytes by dietary selenium. J. Nutr. 1972, 102, 689-696.
87. Aviram, M.; Fuhrman, B. LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: Role of prooxidants vs. antioxidants. Mol. Cell. Biochem. 1998, 188, 149-159.
88. Navas-Acien, A.; Bleys, J.; Guallar, E. Selenium intake and cardiovascular risk: What is new? Curr. Opin. Lipidol. 2008, 19, 43-49.
89. Xun, P.; Liu, K.; Morris, J. S.; Daviglus, M. L.; He, K. Longitudinal association between toenail selenium levels and measures of subclinical atherosclerosis: The CARDIA trace element study. Atherosclerosis 2010, 210, 662-667.
90. Loscalzo, J. Effects of nationwide addition of selenium to fertilizers on foods, and animal and human health in Finland: From deficiency to optimal selenium status of the population. J. Trace Elem. Med. Biol. 2014, 370, 1756-1760.
91. Bleys, J.; Navas-Acien, A.; Guallar, E. Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch. Intern. Med. 2008, 168, 404-410.
92. Joseph, J. Selenium and cardiometabolic health: Inconclusive yet intriguing evidence. Am. J. Med. Sci. 2013, 346, 216-220.
93. González, J.; Valls, N.; Brito, R.; Rodrigo, R. Essential hypertension and oxidative stress: New insights. World J. Cardiol. 2014, 6, 353-366.
94. Nawrot, T. S.; Staessen, J. A.; Roels, H. A.; Den Hond, E.; Thijs, L.; Fagard, R. H.; Dominiczak, A. F.; Struijker-Boudier, H. A. Blood pressure and blood selenium: A cross-sectional and longitudinal population study. Eur. Heart J. 2007, 28, 628-633.
95. Berthold, H. K.; Michalke, B.; Krone, W.; Guallar, E.; Gouni-Berthold, I. Influence of serum selenium concentrations on hypertension: The Lipid Analytic Cologne cross-sectional study. J. Hypertens. 2012, 30, 1328-1335.
96. Forceville, X.; Mostert, V.; Pierantoni, A.; Vitoux, D.; le Toumelin, P.; Plouvier, E.; Dehoux, M.; Thuillier, F.; Combes, A.; Selenoprotein, P. Rather than Glutathione Peroxidase, as a Potential Marker of Septic Shock and Related Syndromes. Eur. Surg. Res. 2009, 43, 338-347.
97. Yang, S. J.; Hwang, S. Y.; Choi, H. Y.; Yoo, H. J.; Seo, J. A.; Kim, S. G.; Kim, N. H.; Baik, S. H.; Choi, D. S.; Choi, K. M. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: Implications for insulin resistance, inflammation, and atherosclerosis. J. Clin. Endocrinol. Metab. 2011, 96, E1325-E1329.
98. Chen, Y. R.; Zweier, J. L. Cardiac mitochondria and reactive oxygen species generation. Circ. Res. 2014, 114, 524-537.
99. Grieve, D. J.; Byrne, J. A.; Cave, A. C.; Shah, A. M. Role of oxidative stress in cardiac remodelling after myocardial infarction. Heart Lung Circ. 2004, 13, 132-138.
100. Tsutsui, H.; Kinugawa, S.; Matsushima, S. Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc. Res. 2009, 81, 449-456.
101. Kutil, B.; Ostadal, P.; Vejvoda, J.; Kukacka, J.; Cepova, J.; Alan, D.; Krüger, A.; Vondrakova, D. Alterations in serum selenium levels and their relation to troponin I in acute myocardial infarction. Mol. Cell. Biochem. 2010, 345, 23-27.
102. Lubos, E.; Sinning, C. R.; Schnabel, R. B.; Wild, P. S.; Zeller, T.; Rupprecht, H. J.; Bickel, C.; Lackner, K. J.; Peetz, D.; Loscalzo, J.; et al. Serum selenium and prognosis in cardiovascular disease: Results from the AtheroGene study. Atherosclerosis 2010, 209, 271-277.
103. Eaton, C. B.; Abdul Baki, A. R.; Waring, M. E.; Roberts, M. B.; Lu, B. The association of low selenium and renal insufficiency with coronary heart disease and all-cause mortality: NHANES III follow-up study. Atherosclerosis 2010, 212, 689-694.
104. Hercberg, S.; Galan, P.; Preziosi, P.; Bertrais, S.; Mennen, L.; Malvy, D.; Roussel, A. M.; Favier, A.; Briancon, S. The SU. VI. MAX Study: A randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch. Intern. Med. 2004, 164, 2335-2342.
105. Hercberg, S.; Bertrais, S.; Czernichow, S.; Noisette, N.; Galan, P.; Jaouen, A.; Tichet, J.; Briancon, S.; Favier, A.; Mennen, L.; et al. Alterations of the lipid profile after 7. 5 years of low-dose antioxidant supplementation in the SU. VI. MAX Study. Lipids 2005, 40, 335-342.
106. McKeag, N. A.; McKinley, M. C.; Woodside, J. V.; Harbinson, M. T.; McKeown, P. P. The role of micronutrients in heart failure. J. Acad. Nutr. Diet. 2012, 112, 870-886.
107. Do Brasil, P. E. A. A.; de Souza, A. P.; Hasslocher-Moreno, A. M.; Xavier, S. S.; Passos, S. R. L.; Moreira, M. D. F. R.; de Oliveira, M. S.; da Silva, G. M. S.; Saraiva, R. M.; de Aguiar, C. C. S.; et al. Selenium Treatment and Chagasic Cardiopathy (STCC): Study protocol for a double-blind randomized controlled trial. Trials 2014, 15, 388.
108. Grover, A.; Gorman, K.; Dall, T. M.; Jonas, R.; Lytle, B.; Shemin, R.; Wood, D.; Kron, I. Shortage of cardiothoracic surgeons is likely by 2020. Circulation 2009, 120, 488-494.
109. Ghosh, P.; Schistek, R.; Unger, F. Coronary revascularization in DACH: 1991-2002. Thorac. Cardiovasc. Surg. 2004, 52, 356-364.
110. Stevanovic, A.; Coburn, M.; Menon, A.; Rossaint, R.; Heyland, D.; Schalte, G.; Werker, T.; Wonisch, W.; Kiehntopf, M.; Goetzenich, A.; et al. The importance of intraoperative selenium blood levels on organ dysfunction in patients undergoing off-pump cardiac surgery: A randomised controlled trial. PLoS ONE 2014, 9, e104222.
111. Hall, R. Identification of inflammatory mediators and their modulation by strategies for the management of the systemic inflammatory response during cardiac surgery. J. Cardiothorac. Vasc. Anesth. 2013, 27, 983-1033.
112. Manzanares, W.; Langlois, P. L.; Heyland, D. K. Pharmaconutrition With Selenium in Critically Ill Patients: What Do We Know? Nutr. Clin. Pract. 2015, 30, 34-43.
113. Stoppe, C.; Schalte, G.; Rossaint, R.; Coburn, M.; Graf, B.; Spillner, J.; Marx, G.; Rex, S. The intraoperative decrease of selenium is associated with the postoperative development of multiorgan dysfunction in cardiac surgical patients. Crit. Care Med. 2011, 39, 1879-1885.
114. Koszta, G.; Kacska, Z.; Szatmari, K.; Szerafin, T.; Fulesdi, B. Lower whole blood selenium level is associated with higher operative risk and mortality following cardiac surgery. J. Anesth. 2012, 26, 812-821.
115. Leong, J. Y.; van der Merwe, J.; Pepe, S.; Bailey, M.; Perkins, A.; Lymbury, R.; Esmore, D.; Marasco, S.; Rosenfeldt, F. Perioperative metabolic therapy improves redox status and outcomes in cardiac surgery patients: A randomised trial. Heart Lung Circ. 2010, 19, 584-591.
116. Stoppe, C.; Spillner, J.; Rossaint, R.; Coburn, M.; Schalte, G.; Wildenhues, A.; Marx, G.; Rex, S. Selenium blood concentrations in patients undergoing elective cardiac surgery and receiving perioperative sodium selenite. Nutrition 2013, 29, 158-165.
117. Stoppe, C.; McDonald, B.; Rex, S.; Manzanares, W.; Whitlock, R.; Fremes, S.; Fowler, R.; Lamarche, Y.; Meybohm, P.; Haberthur, C.; et al. SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX-trial): Study design of an international multicenter randomized double-blinded controlled trial of high dose sodium-selenite administration in high-risk cardiac surgical patients. Trials 2014, 15, 339.
118. Robinson, M. F.; Godfrey, P. J.; Thomson, C. D.; Rea, H. M.; van Rij, A. M. Blood selenium and glutathione peroxidase activity in normal subjects and in surgical patients with and without cancer in New Zealand. Am. J. Clin. Nutr. 1979, 32, 1477-1485.
119. Laffey, J. G.; Boylan, J. F.; Cheng, D. C. H. The systemic inflammatory response to cardiac surgery: Implications for the anesthesiologist. Anesthesiology 2002, 97, 215-252.
120. Méplan, C.; Nicol, F.; Burtle, B. T.; Crosley, L. K.; Arthur, J. R.; Mathers, J. C.; Hesketh, J. E. Relative abundance of selenoprotein P isoforms in human plasma depends on genotype, se intake, and cancer status. Antioxid. Redox Signal. 2009, 11, 2631-2640.
121. Méplan, C.; Hughes, D. J.; Pardini, B.; Naccarati, A.; Soucek, P.; Vodickova, L.; Hlavatá, I.; Vrána, D.; Vodicka, P.; Hesketh, J. E. Genetic variants in selenoprotein genes increase risk of colorectal cancer. Carcinogenesis 2010, 31, 1074-1079.
122. Hill, K. E.; Xia, Y.; Akesson, B.; Boeglin, M. E.; Burk, R. F. Selenoprotein P concentration in plasma is an index of selenium status in selenium-deficient and selenium-supplemented Chinese subjects. J. Nutr. 1996, 126, 138-145.
123. Wang, W. Z.; Guo, X.; Duan, C.; Ma, W. J.; Zhang, Y. G.; Xu, P.; Gao, Z. Q.; Wang, Z. F.; Yan, H.; Zhang, Y. F.; et al. Comparative analysis of gene expression profiles between the normal human cartilage and the one with endemic osteoarthritis. Osteoarthr. Cartil. 2009, 17, 83-90.
124. Speckmann, B.; Grune, T. Epigenetic effects of selenium and their implications for health. Epigenetics 2015, 10, 179-190.
125. Treska, V.; Kuntscher, V.; Hasman, D.; Neprasová, P.; Kobr, J.; Racek, J.; Trefil, L.; Hes, O. Importance of selenium for the influence of ischemia-reperfusion syndrome after kidney transplantation from a non-heart beating donor in a pig model. Transplant. Proc. 2002, 34, 3057-3059.